Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in CAD
The 2 analysts offering 12 month price targets for Cardiol Therapeutics Inc have a median target of 9.75, with a high estimate of 11.00 and a low estimate of 8.50. The median estimate represents a 339.19% increase from the last price of 2.22.
High | 395.5% | 11.00 |
Med | 339.2% | 9.75 |
Low | 282.9% | 8.50 |
Earnings history & estimates in CAD
The next earnings announcement is expected on Mar 31, 2025.
Average growth rate | -25.36% |
Average growth rate | +1.77% |
More ▼
Revenue history & estimates in CAD
Average growth rate | 0.00% |
Average growth rate | -33.33% |
More ▼